ZA200900031B - Improvements relating to nanodispersions - Google Patents
Improvements relating to nanodispersionsInfo
- Publication number
- ZA200900031B ZA200900031B ZA200900031A ZA200900031A ZA200900031B ZA 200900031 B ZA200900031 B ZA 200900031B ZA 200900031 A ZA200900031 A ZA 200900031A ZA 200900031 A ZA200900031 A ZA 200900031A ZA 200900031 B ZA200900031 B ZA 200900031B
- Authority
- ZA
- South Africa
- Prior art keywords
- nanodispersions
- improvements relating
- relating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0613925.7A GB0613925D0 (en) | 2006-07-13 | 2006-07-13 | Improvements relating to nanodispersions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900031B true ZA200900031B (en) | 2010-04-28 |
Family
ID=36955583
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900031A ZA200900031B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to nanodispersions |
ZA200900027A ZA200900027B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to anti-parasitic compositions |
ZA200900028A ZA200900028B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to pharmaceutical compositions |
ZA200900029A ZA200900029B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to biocidal compositions |
ZA200900030A ZA200900030B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to pharmaceutical compositions |
ZA200900347A ZA200900347B (en) | 2006-07-13 | 2007-07-13 | Preparation of pharmaceutical compositions |
ZA200900345A ZA200900345B (en) | 2006-07-13 | 2007-07-13 | Preparation of pharmaceutical formulations |
Family Applications After (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900027A ZA200900027B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to anti-parasitic compositions |
ZA200900028A ZA200900028B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to pharmaceutical compositions |
ZA200900029A ZA200900029B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to biocidal compositions |
ZA200900030A ZA200900030B (en) | 2006-07-13 | 2007-06-29 | Improvements relating to pharmaceutical compositions |
ZA200900347A ZA200900347B (en) | 2006-07-13 | 2007-07-13 | Preparation of pharmaceutical compositions |
ZA200900345A ZA200900345B (en) | 2006-07-13 | 2007-07-13 | Preparation of pharmaceutical formulations |
Country Status (17)
Country | Link |
---|---|
US (10) | US8821932B2 (de) |
EP (8) | EP2040677B1 (de) |
JP (9) | JP2009542763A (de) |
CN (11) | CN102631874A (de) |
AP (1) | AP2008004713A0 (de) |
AR (4) | AR061992A1 (de) |
AU (9) | AU2007271828B2 (de) |
BR (8) | BRPI0714179A2 (de) |
CA (8) | CA2659666A1 (de) |
CL (4) | CL2007002031A1 (de) |
ES (2) | ES2752460T3 (de) |
GB (1) | GB0613925D0 (de) |
IL (2) | IL195911A0 (de) |
MX (2) | MX2009000307A (de) |
TW (1) | TW200812694A (de) |
WO (8) | WO2008006715A2 (de) |
ZA (7) | ZA200900031B (de) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0501833D0 (en) * | 2005-01-28 | 2005-03-09 | Unilever Plc | Carrier liquids and methods of production thereof |
US20090130212A1 (en) * | 2006-05-15 | 2009-05-21 | Physical Pharmaceutica, Llc | Composition and improved method for preparation of small particles |
GB0613925D0 (en) * | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
WO2008022651A1 (en) | 2006-08-21 | 2008-02-28 | Antoine Turzi | Process and device for the preparation of platelet rich plasma for extemporaneous use and combination thereof with skin and bone cells |
AR063704A1 (es) * | 2006-09-14 | 2009-02-11 | Makhteshim Chem Works Ltd | Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones |
US8653066B2 (en) | 2006-10-09 | 2014-02-18 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
AR067047A1 (es) * | 2007-06-18 | 2009-09-30 | Combino Pharm Sl | Formulaciones acuosas de acetaminofen para inyeccion. |
AR067048A1 (es) * | 2007-06-18 | 2009-09-30 | Combino Pharm Sl | Formulaciones acuosas de acetaminofen para inyeccion. |
HUE043897T2 (hu) | 2007-09-25 | 2019-09-30 | Solubest Ltd | Lipofil hatóanyagot tartalmazó készítmények és eljárás elõállításukra |
CA3066426A1 (en) | 2008-01-09 | 2009-07-16 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
TR200800634A2 (tr) * | 2008-01-30 | 2009-02-23 | Takka Sevgi̇ | Uzatılmış salım sağlayan fluvastatin tablet. |
WO2009114648A1 (en) * | 2008-03-11 | 2009-09-17 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
US8372432B2 (en) * | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
EP2305029B1 (de) * | 2008-07-11 | 2018-06-13 | Nippon Soda Co., Ltd. | Verfahren zur herstellung einer präparatzusammensetzung mit verlängerter freisetzung |
GB0814953D0 (en) * | 2008-08-18 | 2008-09-24 | Unilever Plc | Improvements relating to nanodisperse compositions |
CA2737452C (en) | 2008-09-25 | 2018-05-22 | Vive Nano Inc. | Methods to produce polymer nanoparticles and formulations of active ingredients |
FR2938433B1 (fr) * | 2008-11-19 | 2011-09-09 | Francois Fauran | Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation |
NZ593327A (en) * | 2008-12-12 | 2014-11-28 | Tim Tech Chemicals Ltd | Compositions for the treatment of timber and other wood substrates |
EP2243477A1 (de) | 2009-04-22 | 2010-10-27 | Fresenius Kabi Deutschland GmbH | Paracetamol zur parenteralen Verabreichung |
NZ596610A (en) * | 2009-05-27 | 2014-04-30 | Samyang Biopharmaceuticals | A poorly soluble drug containing microsphere with improved bioavailability and method of preparing the same |
HUP0900376A2 (en) * | 2009-06-19 | 2011-01-28 | Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag | Nanoparticulate candesartan cilexetil composition |
HUP0900384A2 (en) * | 2009-06-19 | 2011-01-28 | Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag | Nanoparticulate olmesartan medoxomil compositions |
CN102802611B (zh) * | 2009-06-25 | 2014-11-12 | 进洋制药株式会社 | 含氯沙坦羧酸的药物组合物及其生产方法 |
EP2451274B1 (de) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
EP2473195A4 (de) * | 2009-08-31 | 2013-01-16 | Depomed Inc | Pharmazeutische zusammensetzungen zur magenretention für sofortige und verlängerte freisetzung von acetaminophen |
JP5498769B2 (ja) * | 2009-12-04 | 2014-05-21 | 花王株式会社 | 脂溶性薬物内包ナノ粒子の製造方法 |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
SI2536396T1 (sl) | 2010-02-16 | 2017-01-31 | KRKA, tovarna zdravil, d.d.,Novo mesto | Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan |
WO2011121515A1 (en) | 2010-03-29 | 2011-10-06 | Firmenich Sa | Spray-dried crystalline active ingredient |
GB201006038D0 (en) | 2010-04-12 | 2010-05-26 | Unilever Plc | Improvements relating to antiviral compositions |
UA111167C2 (uk) * | 2010-08-05 | 2016-04-11 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Пестицидні композиції мезорозмірних частинок з підсиленою дією |
EP2624819A1 (de) | 2010-10-05 | 2013-08-14 | Iota NanoSolutions Limited | Verfahren zur herstellung von verbesserten zusammensetzungen |
US9107983B2 (en) | 2010-10-27 | 2015-08-18 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising statins |
US8877221B2 (en) | 2010-10-27 | 2014-11-04 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same |
WO2012082765A2 (en) | 2010-12-16 | 2012-06-21 | The United State Of America. As Represented By The Secretary Department Of Health And Human Services | Methods for decreasing body weight and treating diabetes |
CA2832611C (en) | 2011-04-12 | 2019-05-14 | Rigel Pharmaceuticals, Inc. | Methods for inhibiting allograft rejection |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
WO2012170417A2 (en) | 2011-06-06 | 2012-12-13 | Warsaw Orthopedic, Inc. | Methods and compositions to enhance bone growth comprising a statin |
JP2013001771A (ja) * | 2011-06-14 | 2013-01-07 | Neos Co Ltd | 液状カビ防除洗浄剤組成物 |
RU2469536C1 (ru) * | 2011-06-16 | 2012-12-20 | Государственное бюджетное учреждение Республики Башкортостан "Научно-исследовательский технологический институт гербицидов и регуляторов роста растений с опытно-экспериментальным производством Академии наук Республики Башкортостан" | Фунгицидное средство и способ его получения |
KR20140057414A (ko) | 2011-06-22 | 2014-05-12 | 바이옴 바이오사이언스 피브이티. 엘티디. | 컨쥬게이트계 항진균 및 항세균 프로드러그 |
AU2012311247B2 (en) | 2011-08-23 | 2016-10-13 | Vive Crop Protection Inc. | Pyrethroid formulations |
GB201115079D0 (en) | 2011-08-31 | 2011-10-19 | Iota Nanosolutions Ltd | Method of preparing carrier liquids |
GB201115634D0 (en) | 2011-09-09 | 2011-10-26 | Univ Liverpool | Compositions of lopinavir |
GB201115633D0 (en) | 2011-09-09 | 2011-10-26 | Univ Liverpool | Compositions of efavirenz |
GB201115635D0 (en) | 2011-09-09 | 2011-10-26 | Univ Liverpool | Compositions of lopinavir and ritonavir |
US8609684B2 (en) | 2011-12-12 | 2013-12-17 | PruGen IP Holdings, Inc. | Solubilization and bioavailability of acetaminophen |
AU2012356330B2 (en) | 2011-12-22 | 2016-09-29 | Vive Crop Protection Inc. | Strobilurin formulations |
JP6247685B2 (ja) * | 2012-05-16 | 2017-12-13 | メワ・シン | 実質的に水不溶性の薬物の送達のための医薬組成物 |
US9730885B2 (en) | 2012-07-12 | 2017-08-15 | Mallinckrodt Llc | Extended release, abuse deterrent pharmaceutical compositions |
US20140073678A1 (en) * | 2012-09-12 | 2014-03-13 | Monosol Rx, Llc | Anti-pain and anti-nausea and/or vomiting combinatorial compositions |
EA201592236A1 (ru) | 2013-06-04 | 2016-06-30 | Вайом Байосайнсиз Пвт. Лтд. | Частицы с нанесенным покрытием и композиции, включающие такие частицы |
CA3042642A1 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
CN105828833A (zh) | 2013-10-21 | 2016-08-03 | 萨克生物研究学院 | 突变的成纤维细胞生长因子(fgf)1及使用方法 |
LT3069733T (lt) * | 2013-11-13 | 2022-11-25 | National Defense Education And Research Foundation | Nauja acetaminofeno junginio sudėtis be šalutinio poveikio kepenims |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
MX2016011517A (es) | 2014-03-07 | 2017-04-13 | Univ Arizona | Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico. |
EP2952208A1 (de) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalkoholisches System zur Nagelbehandlung |
EP3154528B1 (de) | 2014-06-11 | 2023-04-05 | SpecGx LLC | Sprühgetrocknete zusammensetzungen mit verschiedenen auflösungsprofilen und verfahren zu deren herstellung |
CN104042626A (zh) * | 2014-07-01 | 2014-09-17 | 李绍明 | 杀菌抑菌剂 |
US9707184B2 (en) | 2014-07-17 | 2017-07-18 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
CA2964628A1 (en) | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
JP2018502742A (ja) * | 2014-12-23 | 2018-02-01 | ダウ グローバル テクノロジーズ エルエルシー | 処理済み多孔質材料 |
JP6730315B2 (ja) * | 2015-01-20 | 2020-07-29 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | 担体ポリマーとしてのポリビニルアルコールを用いた化合物の固体分散体 |
CN104798772B (zh) * | 2015-03-13 | 2017-05-24 | 中国农业科学院农业环境与可持续发展研究所 | 一种农药纳米固体分散体及其制备方法 |
EP3316865A4 (de) | 2015-07-02 | 2019-01-23 | Civitas Therapeutics, Inc. | Triptanpulver zur pulmonalen verabreichung |
US10206904B2 (en) | 2015-07-17 | 2019-02-19 | The Board Of Regents Of The University Of Oklahoma | Licofelone derivatives and methods of use |
CN105145553A (zh) * | 2015-10-12 | 2015-12-16 | 广西田园生化股份有限公司 | 一种难溶农药的固体分散体组合物 |
JP2019504089A (ja) * | 2016-02-02 | 2019-02-14 | エボニック デグサ ゲーエムベーハーEvonik Degussa GmbH | 固体状水溶性担体上の界面活性物質の粉末状調製物、その製造方法およびその使用 |
WO2017152130A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
EP3471697A1 (de) | 2016-06-16 | 2019-04-24 | The University of Liverpool | Chemische zusammensetzung |
RU2619249C1 (ru) * | 2016-11-07 | 2017-05-12 | Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения Российской академии наук (ИХТТМ СО РАН) | Композиция для протравливания семян и способ её получения |
WO2018160772A1 (en) | 2017-02-28 | 2018-09-07 | The United State Of America, As Represented By The Secretary, Department Of Health & Human Services | Method of treating obesity, insulin resistance, non-alcoholic fatty liver disease including non-alcoholic steatohepatitis |
JP2020515607A (ja) | 2017-03-31 | 2020-05-28 | ザ ユニバーシティー オブ リヴァプール | プロドラッグ組成物 |
JP6960475B2 (ja) * | 2017-06-15 | 2021-11-05 | サビオール ライフテック コーポレーションSavior Lifetec Corporation | 有効成分粒子の製造方法 |
WO2019038642A1 (en) | 2017-08-25 | 2019-02-28 | Vive Crop Protection Inc. | MULTI-COMPONENT PESTICIDE COMPOSITIONS APPLIED TO SOIL |
US20210361639A1 (en) | 2018-03-02 | 2021-11-25 | The University Of Liverpool | Solid compositions of actives, processes for preparing same and uses of such solid compositions |
JP6858729B2 (ja) * | 2018-05-25 | 2021-04-14 | ▲財▼▲団▼法人国防教育研究基金会National Defense Education And Research Foundation | 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成 |
WO2020135600A1 (zh) * | 2018-12-28 | 2020-07-02 | 南京善思生物科技有限公司 | 纳米农药制剂及其制备方法 |
CN109846821B (zh) * | 2019-01-03 | 2021-07-06 | 昆药集团股份有限公司 | 一种蒿甲醚纳米制剂及其制备方法 |
WO2020186187A1 (en) | 2019-03-13 | 2020-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for treating bladder and urethra dysfunction and disease |
CN110074993A (zh) * | 2019-06-05 | 2019-08-02 | 山东大学 | 一种制备紫外吸收剂纳米颗粒的方法 |
BR112021026499A2 (pt) * | 2019-06-28 | 2022-03-03 | Solstar Pharma | Formulação gastrorretentiva de liberação prolongada contra helicobacter pylori |
WO2021062012A1 (en) | 2019-09-25 | 2021-04-01 | Emory University | Use of klk10 and engineered derivatizations thereof |
WO2021085395A1 (ja) * | 2019-10-28 | 2021-05-06 | クミアイ化学工業株式会社 | 農薬組成物およびその製造方法 |
JP2023510186A (ja) | 2020-01-17 | 2023-03-13 | ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンテッド バイ ザ セクレタリー、デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Crx常染色体優性網膜症の処置のための遺伝子治療 |
US20230181672A1 (en) | 2020-05-07 | 2023-06-15 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms |
IT202000022789A1 (it) | 2020-09-28 | 2020-12-28 | Vitop Moulding Srl | Rubinetto erogatore provvisto di sistema di collocamento, bloccaggio e orientamento su scatole di tipo Bag-In-Box |
GB202115049D0 (en) | 2021-10-20 | 2021-12-01 | Univ Liverpool | Chemical Compositions |
WO2023196898A1 (en) | 2022-04-07 | 2023-10-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Beta globin mimetic peptides and their use |
CN114732009B (zh) * | 2022-06-13 | 2022-08-23 | 山东百农思达生物科技有限公司 | 一种含有吡唑醚菌酯和烯酰吗啉的水分散粒剂的制备方法 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB501835A (en) | 1936-05-29 | 1939-03-02 | Siemens Ag | Process and apparatus for reducing the power required for the mechanical treatment of movable masses |
GB1305024A (de) * | 1969-07-10 | 1973-01-31 | ||
GB1554662A (en) * | 1976-05-05 | 1979-10-24 | Inverni Della Beffa Spa | Polyhydroxyphenylchromanones |
US4230687A (en) * | 1978-05-30 | 1980-10-28 | Griffith Laboratories U.S.A., Inc. | Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices |
DE3439482A1 (de) * | 1984-10-27 | 1986-05-07 | Röhm GmbH, 6100 Darmstadt | Verfahren zur beschichtung von substraten mit kratzfesten, nichtreflektierenden ueberzuegen |
US4830858A (en) * | 1985-02-11 | 1989-05-16 | E. R. Squibb & Sons, Inc. | Spray-drying method for preparing liposomes and products produced thereby |
US5160530A (en) * | 1989-01-24 | 1992-11-03 | Griffin Corporation | Microencapsulated polymorphic agriculturally active material |
GB8918807D0 (en) * | 1989-08-17 | 1989-09-27 | Shell Int Research | A solid pesticidal formulation,a process for its preparation and the use thereof |
JP3067810B2 (ja) * | 1990-12-21 | 2000-07-24 | 中外製薬株式会社 | 経口投与用o/w型エマルジョンの乾燥粉末製造法 |
GB9304294D0 (en) * | 1993-03-03 | 1993-04-21 | Zeneca Ltd | Herbicidal compositions |
DE4329446A1 (de) * | 1993-09-01 | 1995-03-02 | Basf Ag | Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen |
US5858398A (en) * | 1994-11-03 | 1999-01-12 | Isomed Inc. | Microparticular pharmaceutical compositions |
TW318777B (de) * | 1995-06-29 | 1997-11-01 | Novartis Ag | |
WO1997013503A1 (en) | 1995-10-13 | 1997-04-17 | The Penn State Research Foundation | Synthesis of drug nanoparticles by spray drying |
GB9606188D0 (en) | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
US5858409A (en) * | 1996-04-17 | 1999-01-12 | Fmc Corporation | Hydrolyzed cellulose granulations for pharmaceuticals |
US5985248A (en) | 1996-12-31 | 1999-11-16 | Inhale Therapeutic Systems | Processes for spray drying solutions of hydrophobic drugs and compositions thereof |
JP4183279B2 (ja) * | 1997-04-15 | 2008-11-19 | アール ピー シェーラー テクノロジーズ インコーポレーテッド | 医薬用加水分解セルロース顆粒 |
US6544542B1 (en) * | 1998-03-05 | 2003-04-08 | Nippon Shinyaku Co., Ltd. | Fat emulsions for inhalational administration |
JPH11322587A (ja) | 1998-05-18 | 1999-11-24 | Sumitomo Chem Co Ltd | 常温で固体の生理活性物質のマイクロカプセル化方法およびこの方法により得られるマイクロカプセル組成物 |
WO2000040220A1 (en) * | 1999-01-06 | 2000-07-13 | Korea Research Institute Of Chemical Technology | Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same |
ATE400252T1 (de) * | 1999-02-10 | 2008-07-15 | Pfizer Prod Inc | Pharmazeutische feste dispersionen |
GB9904012D0 (en) | 1999-02-22 | 1999-04-14 | Zeneca Ltd | Agrochemical formulation |
US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US7919119B2 (en) * | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
CA2371836C (en) * | 1999-05-27 | 2006-01-31 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6610317B2 (en) * | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
GB9920148D0 (en) | 1999-08-25 | 1999-10-27 | Smithkline Beecham Plc | Novel composition |
DE60024491T2 (de) | 1999-12-01 | 2006-08-10 | Natco Pharma Ltd., Banjara Hills | Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne |
KR100694667B1 (ko) * | 1999-12-08 | 2007-03-14 | 동아제약주식회사 | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 |
US6207674B1 (en) * | 1999-12-22 | 2001-03-27 | Richard A. Smith | Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
WO2001089484A2 (en) | 2000-05-22 | 2001-11-29 | Verion, Inc. | Method for increasing the compressibility of poorly binding powder materials |
US6932963B2 (en) * | 2000-06-23 | 2005-08-23 | Nicholas V. Perricone | Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
IT1318618B1 (it) | 2000-07-10 | 2003-08-27 | A C R Applied Coating Res S A | Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi. |
EP1304106A4 (de) * | 2000-07-24 | 2005-01-19 | Ono Pharmaceutical Co | GEFRIERGETROCKNETE ZUBEREITUNG VON N-o-(p-PIVALOYLOXYBENZENESULFONYLAMINO) BENZOYL] GLYCIN MONOSODIUM SALZ TETRAHYDRAT UND VERFAHREN ZUR DEREN HERSTELLUNG |
DE10036871A1 (de) * | 2000-07-28 | 2002-02-14 | Pharmasol Gmbh | Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe |
AU6294501A (en) * | 2000-09-20 | 2002-04-02 | Rtp Pharma Inc | Spray drying process and compositions of fenofibrate |
US6756062B2 (en) * | 2000-11-03 | 2004-06-29 | Board Of Regents University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
US8067032B2 (en) * | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US6862890B2 (en) * | 2001-01-30 | 2005-03-08 | Board Of Regents, University Of Texas System | Process for production of nanoparticles and microparticles by spray freezing into liquid |
US6355675B1 (en) | 2001-05-15 | 2002-03-12 | Isp Investments Inc. | Emulsifiable concentrate of a water-insoluble fungicide |
EP1411900B2 (de) * | 2001-06-01 | 2013-12-04 | Pozen, Inc. | Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid |
JP2004534822A (ja) * | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | 低溶解度および/または酸感受性の薬剤と中和された酸性ポリマーとを含む医薬組成物 |
KR100425226B1 (ko) * | 2001-07-03 | 2004-03-30 | 주식회사 팜트리 | 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법 |
WO2003017659A1 (en) * | 2001-08-21 | 2003-02-27 | Sony Corporation | Information processing system, information processing apparatus, and method |
JP2005504090A (ja) * | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
US20060003012A9 (en) * | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
DE10151392A1 (de) * | 2001-10-18 | 2003-05-08 | Bayer Cropscience Ag | Pulverförmige Feststoff-Formulierungen |
KR20040055798A (ko) * | 2001-11-07 | 2004-06-26 | 바스프 악티엔게젤샤프트 | 시니돈-에틸 함유 고체 작물보호 배합물 및 상응하는 분산액 |
WO2003039249A2 (en) * | 2001-11-07 | 2003-05-15 | Basf Aktiengesellschaft | Nanoparticles comprising a crop protection agent |
PL371416A1 (en) * | 2002-02-01 | 2005-06-13 | Pfizer Products Inc. | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
JP4865989B2 (ja) * | 2002-02-01 | 2012-02-01 | ベンド・リサーチ・インコーポレーテッド | 改良された噴霧乾燥装置を使用する均質な噴霧乾燥された固体の非晶質薬物分散物を製造する方法 |
US6780324B2 (en) * | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
US20040028505A1 (en) * | 2002-06-07 | 2004-02-12 | Bilbrey Robert A. | Document tape binding system with automatic tape feed, tape indicia sensing, spine printing method and post-bind automation mechanisms |
CA2488499C (en) | 2002-06-10 | 2013-03-19 | Elan Pharma International Ltd. | Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
US20030017208A1 (en) * | 2002-07-19 | 2003-01-23 | Francis Ignatious | Electrospun pharmaceutical compositions |
DE10244681A1 (de) * | 2002-09-24 | 2004-04-08 | Boehringer Ingelheim International Gmbh | Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung |
US20040105778A1 (en) * | 2002-10-04 | 2004-06-03 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
CN1176649C (zh) | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
JP2006514698A (ja) * | 2002-10-30 | 2006-05-11 | スフェリックス, インコーポレイテッド | ナノ粒子生物活性物質 |
JP4616009B2 (ja) * | 2002-12-26 | 2011-01-19 | ポーゼン インコーポレイテッド | NSAIDsおよびトリプタンを含有する多層剤型 |
CA2511512C (en) * | 2002-12-27 | 2013-10-29 | Chiron Corporation | Immunogenic compositions containing phospholipid |
CA2513729A1 (en) * | 2003-01-21 | 2004-08-05 | Ranbaxy Laboratories Limited | Co-precipitated amorphous losartan and dosage forms comprising the same |
US20040197301A1 (en) * | 2003-02-18 | 2004-10-07 | Zhong Zhao | Hybrid polymers and methods of making the same |
AU2004212976A1 (en) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories Inc. | Rapid absorption selective 5-HT agonist formulations |
WO2004075921A1 (en) * | 2003-02-26 | 2004-09-10 | Vrije Universiteit Brussel | Inclusion complex of artemisinin or derivates thereof with cyclodextrins |
RU2005134364A (ru) * | 2003-04-08 | 2006-06-10 | Проджиникс Фармасьютикалз, Инк. (Us) | Комбинированное лечение запора |
US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
CA2465565A1 (en) * | 2003-06-12 | 2004-12-12 | Warner-Lambert Company Llc | Pharmaceutical compositions of atorvastatin |
WO2005014043A1 (en) | 2003-07-16 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Chlorthalidone combinations |
US7687167B2 (en) * | 2003-07-18 | 2010-03-30 | Panasonic Corporation | Power supply unit |
CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
DE10338403A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
DE10351004A1 (de) * | 2003-10-30 | 2005-05-25 | Basf Ag | Nanopartikuläre Wirkstoffformulierungen |
DE10351087A1 (de) * | 2003-10-31 | 2005-05-25 | Bayer Technology Services Gmbh | Feste Wirkstoff-Formulierung |
KR100603974B1 (ko) * | 2003-12-05 | 2006-07-25 | 김갑식 | 고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법 |
JP2007517015A (ja) * | 2003-12-31 | 2007-06-28 | ファイザー・プロダクツ・インク | 低溶解性薬物、ポロキサマーおよび安定化ポリマーの安定化された医薬用固体組成物 |
KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
IL160095A0 (en) | 2004-01-28 | 2004-06-20 | Yissum Res Dev Co | Formulations for poorly soluble drugs |
JP2005298347A (ja) * | 2004-04-06 | 2005-10-27 | Yoshiaki Kawashima | 吸入製剤及びその製造方法 |
KR100598326B1 (ko) * | 2004-04-10 | 2006-07-10 | 한미약품 주식회사 | HMG-CoA 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법 |
AU2005237213B2 (en) * | 2004-04-28 | 2008-04-24 | Unilever Plc | Edible oil containing statins |
WO2005117834A1 (en) * | 2004-05-27 | 2005-12-15 | Janssen Pharmaceutica N.V. | Solid dispersions of a basic drug compound and a polymer containing acidic groups |
WO2005117837A1 (en) | 2004-06-01 | 2005-12-15 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Process for preparation of amorphous form of a drug |
DE102004031298A1 (de) | 2004-06-28 | 2006-01-12 | Basf Ag | Wässrige Dispersionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver enthaltend mindestens ein Polyethergruppen enthaltendes Polymer als Schutzkolloid |
US20070298111A1 (en) * | 2004-10-01 | 2007-12-27 | Eisai R&D Management Co., Ltd. | Fine Particle-Containing Composition and Manufacturing Method Therefor |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
CN101132770A (zh) | 2005-01-06 | 2008-02-27 | 伊兰制药国际有限公司 | 纳米微粒坎地沙坦制剂 |
GB0501835D0 (en) * | 2005-01-28 | 2005-03-09 | Unilever Plc | Improvements relating to spray dried compositions |
GB0613925D0 (en) * | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
US20080152717A1 (en) * | 2006-12-14 | 2008-06-26 | Isp Investments, Inc. | Amorphous valsartan and the production thereof |
-
2006
- 2006-07-13 GB GBGB0613925.7A patent/GB0613925D0/en not_active Ceased
-
2007
- 2007-06-29 JP JP2009518834A patent/JP2009542763A/ja active Pending
- 2007-06-29 US US12/309,294 patent/US8821932B2/en active Active
- 2007-06-29 EP EP07765733.6A patent/EP2040677B1/de active Active
- 2007-06-29 JP JP2009518835A patent/JP2009542764A/ja active Pending
- 2007-06-29 JP JP2009518831A patent/JP2009542760A/ja active Pending
- 2007-06-29 US US12/309,295 patent/US20100015233A1/en not_active Abandoned
- 2007-06-29 AU AU2007271828A patent/AU2007271828B2/en not_active Ceased
- 2007-06-29 EP EP07786932.9A patent/EP2040680B1/de active Active
- 2007-06-29 ZA ZA200900031A patent/ZA200900031B/xx unknown
- 2007-06-29 WO PCT/EP2007/056563 patent/WO2008006715A2/en active Application Filing
- 2007-06-29 CN CN2012101088434A patent/CN102631874A/zh active Pending
- 2007-06-29 US US12/309,292 patent/US9060937B2/en active Active
- 2007-06-29 MX MX2009000307A patent/MX2009000307A/es not_active Application Discontinuation
- 2007-06-29 CN CNA2007800262657A patent/CN101489532A/zh active Pending
- 2007-06-29 BR BRPI0714179-3A patent/BRPI0714179A2/pt not_active IP Right Cessation
- 2007-06-29 EP EP07765734A patent/EP2040678A2/de not_active Withdrawn
- 2007-06-29 BR BRPI0722376-5A patent/BRPI0722376A2/pt not_active IP Right Cessation
- 2007-06-29 BR BRPI0714176-9A patent/BRPI0714176A2/pt not_active IP Right Cessation
- 2007-06-29 CN CNA2007800263575A patent/CN101489534A/zh active Pending
- 2007-06-29 AU AU2007271827A patent/AU2007271827B2/en not_active Ceased
- 2007-06-29 EP EP07786933.7A patent/EP2040681B1/de active Active
- 2007-06-29 ZA ZA200900027A patent/ZA200900027B/xx unknown
- 2007-06-29 ES ES07786932T patent/ES2752460T3/es active Active
- 2007-06-29 ES ES07765733T patent/ES2741124T3/es active Active
- 2007-06-29 CA CA002659666A patent/CA2659666A1/en not_active Abandoned
- 2007-06-29 CN CN201010193750A patent/CN101849911A/zh active Pending
- 2007-06-29 WO PCT/EP2007/056560 patent/WO2008006712A2/en active Search and Examination
- 2007-06-29 CA CA002656217A patent/CA2656217A1/en not_active Abandoned
- 2007-06-29 WO PCT/EP2007/056561 patent/WO2008006713A2/en active Application Filing
- 2007-06-29 CN CNA2007800262750A patent/CN101489533A/zh active Pending
- 2007-06-29 CN CN2012101088167A patent/CN102671585A/zh active Pending
- 2007-06-29 WO PCT/EP2007/056564 patent/WO2008006716A2/en active Search and Examination
- 2007-06-29 EP EP20100175541 patent/EP2269581A1/de not_active Withdrawn
- 2007-06-29 AU AU2007271829A patent/AU2007271829B2/en not_active Ceased
- 2007-06-29 CN CNA2007800263679A patent/CN101489535A/zh active Pending
- 2007-06-29 ZA ZA200900028A patent/ZA200900028B/xx unknown
- 2007-06-29 US US12/309,306 patent/US20090175953A1/en not_active Abandoned
- 2007-06-29 BR BRPI0714230-7A patent/BRPI0714230A2/pt not_active IP Right Cessation
- 2007-06-29 AU AU2007271830A patent/AU2007271830B2/en not_active Ceased
- 2007-06-29 ZA ZA200900029A patent/ZA200900029B/xx unknown
- 2007-06-29 CA CA2656229A patent/CA2656229C/en active Active
- 2007-06-29 AU AU2007271831A patent/AU2007271831B2/en not_active Ceased
- 2007-06-29 EP EP11005053A patent/EP2387992A1/de not_active Ceased
- 2007-06-29 ZA ZA200900030A patent/ZA200900030B/xx unknown
- 2007-06-29 EP EP11005052A patent/EP2386292A1/de active Pending
- 2007-06-29 CA CA002656223A patent/CA2656223A1/en not_active Abandoned
- 2007-06-29 JP JP2009518833A patent/JP2009542762A/ja active Pending
- 2007-06-29 AP AP2008004713A patent/AP2008004713A0/xx unknown
- 2007-06-29 US US12/309,293 patent/US20090239749A1/en not_active Abandoned
- 2007-06-29 WO PCT/EP2007/056562 patent/WO2008006714A2/en active Application Filing
- 2007-06-29 CA CA002656233A patent/CA2656233A1/en not_active Abandoned
- 2007-06-29 EP EP07786931A patent/EP2040679A2/de not_active Ceased
- 2007-06-29 CN CNA2007800262267A patent/CN101489531A/zh active Pending
- 2007-06-29 MX MX2009000309A patent/MX2009000309A/es not_active Application Discontinuation
- 2007-06-29 BR BRPI0714177-7A patent/BRPI0714177A2/pt not_active IP Right Cessation
- 2007-06-29 JP JP2009518832A patent/JP2009542761A/ja active Pending
- 2007-07-11 TW TW096125298A patent/TW200812694A/zh unknown
- 2007-07-12 CL CL2007002031A patent/CL2007002031A1/es unknown
- 2007-07-12 CL CL2007002030A patent/CL2007002030A1/es unknown
- 2007-07-12 CL CL2007002032A patent/CL2007002032A1/es unknown
- 2007-07-13 BR BRPI0714351-6A patent/BRPI0714351A2/pt not_active IP Right Cessation
- 2007-07-13 ZA ZA200900347A patent/ZA200900347B/xx unknown
- 2007-07-13 WO PCT/GB2007/050409 patent/WO2008007152A2/en active Application Filing
- 2007-07-13 CA CA002657586A patent/CA2657586A1/en not_active Abandoned
- 2007-07-13 ZA ZA200900345A patent/ZA200900345B/xx unknown
- 2007-07-13 BR BRPI0714353-2A patent/BRPI0714353A2/pt not_active Application Discontinuation
- 2007-07-13 US US12/309,341 patent/US7691873B2/en not_active Expired - Fee Related
- 2007-07-13 CN CNA2007800338444A patent/CN101516341A/zh active Pending
- 2007-07-13 WO PCT/GB2007/050408 patent/WO2008007151A2/en active Application Filing
- 2007-07-13 CN CNA2007800338942A patent/CN101516342A/zh active Pending
- 2007-07-13 CN CNA2007800338285A patent/CN101516340A/zh active Pending
- 2007-07-13 CA CA002657548A patent/CA2657548A1/en not_active Abandoned
- 2007-07-13 AR ARP070103118A patent/AR061992A1/es not_active Application Discontinuation
- 2007-07-13 CA CA002657582A patent/CA2657582A1/en not_active Abandoned
- 2007-07-13 AU AU2007274041A patent/AU2007274041A1/en not_active Abandoned
- 2007-07-13 WO PCT/GB2007/050407 patent/WO2008007150A1/en active Application Filing
- 2007-07-13 JP JP2009518978A patent/JP2009542793A/ja active Pending
- 2007-07-13 AR ARP070103116A patent/AR061990A1/es not_active Application Discontinuation
- 2007-07-13 AU AU2007274040A patent/AU2007274040A1/en not_active Abandoned
- 2007-07-13 US US12/309,343 patent/US20100008995A1/en not_active Abandoned
- 2007-07-13 AU AU2007274039A patent/AU2007274039A1/en not_active Abandoned
- 2007-07-13 US US12/309,344 patent/US8945626B2/en not_active Expired - Fee Related
- 2007-07-13 AR ARP070103117A patent/AR061991A1/es not_active Application Discontinuation
- 2007-07-13 JP JP2009518980A patent/JP2009542795A/ja active Pending
- 2007-07-13 BR BRPI0714352-4A patent/BRPI0714352A2/pt not_active IP Right Cessation
- 2007-07-13 JP JP2009518979A patent/JP2009542794A/ja active Pending
-
2008
- 2008-12-11 IL IL195911A patent/IL195911A0/en unknown
- 2008-12-15 IL IL195933A patent/IL195933A/en not_active IP Right Cessation
-
2010
- 2010-05-11 AU AU2010201900A patent/AU2010201900A1/en not_active Abandoned
- 2010-05-19 CL CL2010000516A patent/CL2010000516A1/es unknown
- 2010-06-08 JP JP2010131047A patent/JP2010202665A/ja not_active Withdrawn
- 2010-06-23 AR ARP100102205A patent/AR077195A2/es not_active Application Discontinuation
-
2012
- 2012-02-03 US US13/365,830 patent/US20120135058A1/en not_active Abandoned
- 2012-02-03 US US13/365,826 patent/US20120134940A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195933A0 (en) | Improvements relating to nanodispersions | |
GB2435863B (en) | Folding bicycle | |
GB2422141B (en) | Improvements relating to construction | |
GB0616053D0 (en) | Improvements relating to hose | |
GB0605531D0 (en) | Improvements Relating To Valves | |
GB0612991D0 (en) | Improvements relating to hose | |
GB0609079D0 (en) | Improvements relating to hose | |
GB0616054D0 (en) | Improvements relating to hose | |
GB0616052D0 (en) | Improvements relating to hose | |
HK1119480A1 (en) | Cross-reference to related applications | |
GB0606190D0 (en) | Construct | |
ZA201000260B (en) | Improvements relating to perfumes | |
GB0607398D0 (en) | Compounds | |
EP2082022A4 (de) | Verbindungen | |
GB0600299D0 (en) | Way to go | |
GB0609081D0 (en) | Improvements relating to hose | |
EP1973905A4 (de) | Verbindungen | |
GB0608163D0 (en) | Implement | |
GB0625008D0 (en) | Improvements relating to kerbs | |
GB0600637D0 (en) | Supplement | |
GB0612416D0 (en) | Compounds | |
GB0607839D0 (en) | Compounds | |
GB2423802B (en) | Improvements relating to vacuum-brake-boosters | |
GB0625307D0 (en) | Improvements relating to packaging | |
GB0609083D0 (en) | Improvements relating to hose |